<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Understanding Psilocybin</title>
    <meta name="description" content="Comprehensive guide to understanding the policy models for legalizing psilocybin">
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&display=swap" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&family=Montserrat:ital,wght@0,100..900;1,100..900&display=swap" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css2?family=Asap+Condensed:ital,wght@0,200;0,300;0,400;0,500;0,600;0,700;0,800;0,900;1,200;1,300;1,400;1,500;1,600;1,700;1,800;1,900&family=Bebas+Neue&family=Montserrat:ital,wght@0,100..900;1,100..900&display=swap" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css2?family=Asap+Condensed:ital,wght@0,200;0,300;0,400;0,500;0,600;0,700;0,800;0,900;1,200;1,300;1,400;1,500;1,600;1,700;1,800;1,900&family=Bebas+Neue&family=Montserrat:ital,wght@0,100..900;1,100..900&family=Roboto+Condensed:ital,wght@0,100..900;1,100..900&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="css/style.css">
</head>

<body>
    <header class="header">
        <div class="container">
            <h1 class="main-title" id="main-title">
              <span class="header-inline">
                Understanding Psilocybin
                <span class="megaphone-toggle" id="megaphone-toggle" tabindex="0" aria-label="Toggle call to action" style="width:1.2em; height:1.2em; display:inline-block; vertical-align:-0.2em;">
                  <canvas id="megaphone3d" width="48" height="32" style="width:1.2em; height:1.2em; display:block;"></canvas>
                  <svg id="megaphone-waves" width="48" height="32" viewBox="0 0 48 32" style="position:absolute; left:0.7em; top:0.1em; pointer-events:none;">
                    <g transform="translate(0,-2)">
                    <path class="megaphone-wave wave1" d="M14 16 Q22 8, 30 16" stroke="#2a2a2e" stroke-width="1.5" fill="none" transform="rotate(90 14 16)"/>
                    </g>
                    <g transform="translate(6,-6)">
                    <path class="megaphone-wave wave2" d="M12 18 Q22 6, 32 18" stroke="#3f3f45" stroke-width="1.5" fill="none" transform="rotate(90 12 18)"/>
                    </g>
                    <g transform="translate(12,-10)">
                    <path class="megaphone-wave wave3" d="M10 20 Q22 4, 34 20" stroke="#747480" stroke-width="1.5" fill="none" transform="rotate(90 10 20)"/>
                    </g>
                  </svg>
                </span>
                <span id="cta-bubble" class="cta-bubble" hidden>
                  <span class="cta-bubble-content">
                    We need to make a comprehensive U.S. report across states for 
                    psilocybin use and policy. Help us make this a resource for the US.
                    Contact us at <a href="mailto:up@goinvo.com">up@goinvo.com</a>
                  </span>
                </span>
              </span>
            </h1>
            <p class="body-text">
                As states across the U.S. explore how to legalize 
                and regulate psilocybin, eight distinct policy models 
                have emerged. This matrix outlines these options—ranging 
                from FDA-approved use to state-run monopolies to help 
                identify promising paths toward making psychedelic-assisted 
                mental health treatment more accessible.
            </p>
            <h3 class="subheading"> An <a href="https://github.com/goinvo/understanding-psilocybin">open source</a> work by <a href="https://www.goinvo.com/">GoInvo</a></h3>
            <h4 class="subheading">v0.1 updated 23 June 2025</h4>
        </div>
    </header>

    <main class="main-content">
         <div class="container"> 
            <!-- Featured Grid -->
           <div class="grid">
            <!-- 9 rows × 7 columns = 63 cells -->
             <!-- Row 1 -->
            <!-- <div class="cell invisible"></div> -->
            <div class="cell invisible"></div>
            <div class="cell invisible">
                <p class="state-label-text">
                    CT
                </p>
            </div>
            <div class="cell invisible">
                <p class="state-label-text">
                    MN
                </p>
            </div>
            <div class="cell invisible">
                <p class="state-label-text">
                    VT
                </p>
            </div>
            <div class="cell invisible">
                <p class="state-label-text">
                    NV
                </p>
            </div>
            <div class="cell invisible">
                <p class="state-label-text">
                    WA
                </p>
            </div>

            <!-- Row 2 -->
            <div class="cell invisible">
                <p class="label-text" id="deprior-label">
                  <span class="label-number">1.&nbsp;</span>
                  <span class="label-main">Deprioritization/ Decriminalization</span>
                  <span class="label-desc" style="display:none;">
                    Removal of criminal penalties or enforcement for personal use/possession.
                  </span>
                </p>
            </div>

            <div class="cell shadow0">N/A</div>
            <div class="cell shadow1">Endorsed</div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow2">Supported</div>
            <div class="cell shadow0">N/A</div>

            <!-- Row 3 -->
            <div class="cell invisible">
                <p class="label-text" id="peer-label">
                  <span class="label-number">2.&nbsp;</span>
                  <span class="label-main">Non-Commercial Peer Sharing</span>
                  <span class="label-desc" style="display:none;">
                    Adults may grow and share psychedelics without sale or profit.
                  </span>
                </p>
            </div>
            <div class="cell shadow5">Opposed</div>
            <div class="cell shadow3">Mixed</div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow0">N/A</div>

            <!-- Row 4 -->
            <div class="cell invisible">
                <p class="label-text" id="commercial-label">
                  <span class="label-number">3.&nbsp;</span>
                  <span class="label-main">Commercial Sales</span>
                  <span class="label-desc" style="display:none;">
                    Licensed private businesses, cultivate, sell, and profit in a
                    regulated market.
                  </span>
                </p>
            </div>
            <div class="cell shadow5">Opposed</div>
            <div class="cell shadow3">Mixed</div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow2">Supported</div>

            <!-- Row 5 -->
            <div class="cell invisible">
                <p class="label-text" id="religious-label">
                  <span class="label-number">4.&nbsp;</span>
                  <span class="label-main">Religious Use Exemptions</span>
                  <span class="label-desc" style="display:none;">
                    Use permitted within federally or judicially recognized religious 
                    contexts.
                  </span>
                </p>
            </div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow2">Supported</div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow1">Endorsed</div>

            <!-- Row 6 -->
            <div class="cell invisible">
                <p class="label-text" id="supervised-label">
                  <span class="label-number">5.&nbsp;</span>
                  <span class="label-main">Supervised Adult Use</span>
                  <span class="label-desc" style="display:none;">
                    Adults access psychedelics via licensed facilitators in 
                    non-medical settings. 
                  </span>
                </p>
            </div>
            <div class="cell shadow5">Opposed</div>
            <div class="cell shadow1">Endorsed</div>
            <div class="cell shadow5">Opposed</div>
            <div class="cell shadow1">Endorsed</div>
            <div class="cell shadow1">Endorsed</div>

            <!-- Row 7 -->
            <div class="cell invisible">
                <p class="label-text" id="medical-label">
                  <span class="label-number">6.&nbsp;</span>
                  <span class="label-main">Medical/ Therapeutic Use</span>
                  <span class="label-desc" style="display:none;">
                    Access via clinicians for patients with qualifying diagnoses; 
                    not FDA-approved.
                  </span>
                </p>
            </div>
            <div class="cell shadow1">Endorsed</div>
            <div class="cell shadow1">Endorsed</div>
            <div class="cell shadow3">Mixed</div>
            <div class="cell shadow1">Endorsed</div>
            <div class="cell shadow1">Endorsed</div>

             <!-- Row 8 -->
            <div class="cell invisible">
                <p class="label-text" id="fda-label">
                  <span class="label-number">7.&nbsp;</span>
                  <span class="label-main">FDA-Approved Use</span>
                  <span class="label-desc" style="display:none;">
                    State controls supply, distribution, and pricing; 
                    private retail excluded.
                  </span>
                </p>
            </div>
            <div class="cell shadow1">Endorsed</div>
            <div class="cell shadow5">Opposed</div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow5">Opposed</div>
            <div class="cell shadow5">Opposed</div>

            <!-- Row 9 -->
            <div class="cell invisible">
                <p class="label-text" id="monopoly-label">
                  <span class="label-number">8.&nbsp;</span>
                  <span class="label-main">State Monopoly Sales</span>
                  <span class="label-desc" style="display:none;">
                    Legalizes psilocybin sales only through state-run stores or agencies, prohibiting private commercial sales.
                  </span>
                </p>
            </div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow0">N/A</div>
            </div>

        <!-- Mobile Layout -->
        <div class="mobile-grid">
        <!-- Deprioritization/Decriminalization -->
            <div class="category-block">
                <div class="category-label"><span class="label-number">1.</span> Deprioritization/Decriminalization</div>
                <div class="category-desc">
                  Removal of criminal penalties or enforcement for personal use/possession.
                </div>
                <div class="state-row-group">
                  <div class="state-row"><span class="state-label">CT</span><span class="state-value0">N/A</span></div>
                  <div class="state-row"><span class="state-label">MN</span><span class="state-value1">Endorsed</span></div>
                  <div class="state-row"><span class="state-label">VT</span><span class="state-value0">N/A</span></div>
                  <div class="state-row"><span class="state-label">NV</span><span class="state-value2">Supported</span></div>
                  <div class="state-row"><span class="state-label">WA</span><span class="state-value0">N/A</span></div>
                </div>
            </div>
        <!-- Non-Commercial Peer Sharing -->
            <div class="category-block">
                <div class="category-label"><span class="label-number">2.</span> Non-Commercial Peer Sharing</div>
                <div class="state-row-group">
                    <div class="state-row"><span class="state-label">CT</span><span class="state-value5">Opposed</span></div>
                    <div class="state-row"><span class="state-label">MN</span><span class="state-value3">Mixed</span></div>
                    <div class="state-row"><span class="state-label">VT</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">NV</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">WA</span><span class="state-value0">N/A</span></div>
                </div>
            </div>
        <!-- Commercial Sales -->
            <div class="category-block">
                <div class="category-label"><span class="label-number">3.</span> Commercial Sales</div>
                <div class="state-row-group">
                    <div class="state-row"><span class="state-label">CT</span><span class="state-value5">Opposed</span></div>
                    <div class="state-row"><span class="state-label">MN</span><span class="state-value3">Mixed</span></div>
                    <div class="state-row"><span class="state-label">VT</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">NV</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">WA</span><span class="state-value2">Supported</span></div>
                </div>
            </div>
         <!-- Religious Use Exemptions -->
            <div class="category-block">
                <div class="category-label"><span class="label-number">4.</span> Religious Use Exemptions</div>
                <div class="state-row-group">
                    <div class="state-row"><span class="state-label">CT</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">MN</span><span class="state-value2">Supported</span></div>
                    <div class="state-row"><span class="state-label">VT</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">NV</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">WA</span><span class="state-value1">Endorsed</span></div>
                </div>
            </div>
        <!-- Supervised Adult Use -->
            <div class="category-block">
                <div class="category-label"><span class="label-number">5.</span> Supervised Adult Use</div>
                <div class="state-row-group">
                    <div class="state-row"><span class="state-label">CT</span><span class="state-value5">Opposed</span></div>
                    <div class="state-row"><span class="state-label">MN</span><span class="state-value1">Endorsed</span></div>
                    <div class="state-row"><span class="state-label">VT</span><span class="state-value5">Opposed</span></div>
                    <div class="state-row"><span class="state-label">NV</span><span class="state-value1">Endorsed</span></div>
                    <div class="state-row"><span class="state-label">WA</span><span class="state-value1">Endorsed</span></div>
                </div>
            </div>
        <!-- Medical/Therapeutic Use -->
            <div class="category-block">
                <div class="category-label"><span class="label-number">6.</span> Medical/Therapeutic Use</div>
                <div class="state-row-group">
                    <div class="state-row"><span class="state-label">CT</span><span class="state-value1">Endorsed</span></div>
                    <div class="state-row"><span class="state-label">MN</span><span class="state-value1">Endorsed</span></div>
                    <div class="state-row"><span class="state-label">VT</span><span class="state-value3">Mixed</span></div>
                    <div class="state-row"><span class="state-label">NV</span><span class="state-value1">Endorsed</span></div>
                    <div class="state-row"><span class="state-label">WA</span><span class="state-value1">Endorsed</span></div>
                </div>
            </div>
         <!-- FDA-Approved Use -->
            <div class="category-block">
                <div class="category-label"><span class="label-number">7.</span> FDA-Approved Use</div>
                <div class="state-row-group">
                    <div class="state-row"><span class="state-label">CT</span><span class="state-value1">Endorsed</span></div>
                    <div class="state-row"><span class="state-label">MN</span><span class="state-value5">Opposed</span></div>
                    <div class="state-row"><span class="state-label">VT</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">NV</span><span class="state-value5">Opposed</span></div>
                    <div class="state-row"><span class="state-label">WA</span><span class="state-value5">Opposed</span></div>
                </div>
            </div>
        <!-- State Monopoly Sales -->
            <div class="category-block">
                <div class="category-label"><span class="label-number">8.</span> State Monopoly Sales</div>
                <div class="state-row-group">
                    <div class="state-row"><span class="state-label">CT</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">MN</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">VT</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">NV</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">WA</span><span class="state-value0">N/A</span></div>
                </div>
            </div>
            </div>
        </div>
    </main>
    <header class="header">
        <div class="container">
            <h2 class="main-title">Help us make this real.</h2>
            <p class="body-text">
                We need feedback, funding, and a few brave new allies. <br>
                Send us your feedback at <a href="mailto:up@goinvo.com">up@goinvo.com</a>
            </p>
            <h2 class="main-title">References</h2>
            <ol class="body-text">
              <li>
                BrainFutures. <em>Psychedelic Pathways Report</em>. 2023. 
                <a href="reports/brainfutures-psychedlic-pathways-v3.pdf" target="_blank">PDF</a>
              </li>
              <li>
                Connecticut Department of Mental Health and Addiction Services. <em>Psilocybin Study Final Report</em>. 2023. 
                <a href="reports/CT-Report.pdf" target="_blank">PDF</a>
              </li>
              <li>
                Minnesota Department of Health. <em>Psychedelic Medicine Task Force Report</em>. 2024. 
                <a href="reports/MN-Report.pdf" target="_blank">PDF</a>
              </li>
              <li>
                Nevada State Legislature. <em>Psilocybin Working Group Final Report</em>. 2024. 
                <a href="reports/NV-Report.pdf" target="_blank">PDF</a>
              </li>
              <li>
                Pacula, Rosalie Liccardo, et al. “Current Models of Psilocybin Regulation.” RAND Corporation, 2023. 
                <a href="reports/RAND_RRA2825-1 (1).pdf" target="_blank">PDF</a>
              </li>
              <li>
                Vermont Department of Health. <em>Psychedelic Therapy Report</em>. 2024. 
                <a href="reports/VT-Report.pdf" target="_blank">PDF</a>
              </li>
              <li>
                Washington State Health Care Authority. <em>Psychedelic Work Group Final Report</em>. 2023. 
                <a href="reports/WA-Report.pdf" target="_blank">PDF</a>
              </li>
            </ol>
        </div>
    </header>
<script src="https://cdn.jsdelivr.net/npm/three@0.154.0/build/three.min.js"></script>
<script src="script.js"></script>
  <footer class="site-footer">
  <p><a href="https://www.goinvo.com/">&copy; GoInvo</a> Open source under Creative Commons Attribution v4.</p>
</footer>
</body>
</html>



